| Literature DB >> 24936388 |
Marcus Niewald1, Kristina Mang2, Oliver Barbie1, Jochen Fleckenstein1, Henrik Holtmann3, Wolfgang J Spitzer2, Christian Rübe1.
Abstract
OBJECTIVES: Dental status, dental treatment procedures and radiotherapy dosage as potential risk factors for an infected osteoradionecrosis (IORN) in patients with oral cancers: Retrospective evaluation of 204 patients treated in two observation periods of approximately ten years each. PATIENTS AND METHODS: In group A, 90 patients were treated in the years 1993-2003, in group B 114 patients in the years 1983-1992 (data in brackets). All patients had histopathologically proven squamous cell cancers, mainly UICC stages III and IV. 70% (85%, n.s.) had undergone surgery before radiotherapy. All patients were referred to the oral and maxillofacial surgeon for dental rehabilitation before further treatment. Radiotherapy was performed using a 3D-conformal technique with 4-6MV photons of a linear accelerator (Co-60 device up to 1987). The majority of patients were treated using conventional fractionation with total doses of 60-70 Gy in daily fractions of 2 Gy. Additionally, in group A, hyperfractionation was used applying a total dose of 72 Gy in fractions of 1.2 Gy twice daily (time interval > 6 hours). In group B, a similar schedule was used up to a total dose of 82.8 Gy (time interval 4-6 hours). 14 (0) patients had radiochemotherapy simultaneously. After therapy, the patients were seen regularly by the radiooncologist and - if necessary - by the oral and maxillofacial surgeon. The duration of follow-up was 3.64 years (5 years, p = 0.004).Entities:
Keywords: Dental status; Infected osteoradionecrosis; Oral cancer; Radiotherapy
Year: 2014 PMID: 24936388 PMCID: PMC4048661 DOI: 10.1186/2193-1801-3-263
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
Biographical and oncological data
| Item | Group A | Group B | Remarks | |
|---|---|---|---|---|
| Mean age (years) | 57.1 | 54.6 | n.s. | |
| Mean Karnofsky performance Index | 7.8 | 7.5 | n.s. | |
| Follow-up (years) | 4.1 | 5.0 | p = 0.004 | |
| T-stage | T1 | 14 (16%) | 20 (18%) | n.s. |
| T2 | 33 (37%) | 49 (43%) | ||
| T3 | 8 (9%) | 19 (16%) | ||
| T4 | 35 (38%) | 26 (23%) | ||
| N-stage | N0 | 20 (22%) | 46 (40%) | n.s. |
| N1 | 23 (26%) | 24 (21%) | ||
| N2 | 47 (52%) | 30 (26%) | ||
| N3 | 0 | 14 (13%) | ||
| UICC stage | I | 6 ( 7%) | 10 ( 9%) | n.s. |
| II | 7 (8%) | 22 (19%) | ||
| III | 19 (21%) | 26 (23%) | ||
| IV | 58 (64%) | 56 (49%) | ||
| Pre-treatment | None | 24 (27%) | 17 (15%) | p < 0.001 |
| Surgery | 66 (73%) | 97 (85%) | ||
| Total dose (Gy) | Conventional fractionation | N = 75 | N = 73 | p < 0.001 |
| 30Gy (1) | 2Gy (1) | |||
| 36Gy (1) | 8Gy (1) | |||
| 50Gy (7) | 36Gy (1) | |||
| 58Gy (2) | 44Gy (1) | |||
| 60Gy (32) | 56Gy (1) | |||
| 64Gy (9) | 60Gy (31) | |||
| 70Gy (23) | 62Gy (1) | |||
| 66Gy (1) | ||||
| 70Gy (31) | ||||
| 72Gy (2) | ||||
| 76Gy (1) | ||||
| 80Gy (1) | ||||
| Total dose (Gy) | Hyperfractionation | N = 15 | N = 41 | |
| 55.8Gy (1) | 13.2Gy (1) | |||
| 70.8Gy (1) | 81.6Gy (2) | |||
| 72.0Gy (11) | 82.8Gy (35) | |||
| 72.8Gy (1) | 85.2Gy (1) | |||
| 76.8Gy (1) | 85.5Gy (1) | |||
| 87.8Gy (1) | ||||
| Daily fraction | Conventional fractionation | 2.0 Gy (74) | 2.0Gy (73) | p = 0.0012 |
| 3.0 Gy (1) | ||||
| Hyperfractionation | 1.2 Gy (14) | 1.2 Gy (41) | ||
| 1.4 Gy (1) | ||||
| Simultaneous chemotherapy | 14 | 0 | p < 0.001 |
Dental findings before radiotherapy
| Teeth (mean values, n=) | Group A | Group B | Comparison: | Data available from n patients |
|---|---|---|---|---|
| Absent | 22.0 | 21.2 | n.s. | 204 |
| Present | 10.1 | 10.8 | n.s. | 204 |
| Carious | 2.0 | 2.3 | n.s. | 198 |
| Deeply carious destroyed | 1.4 | 0.3 | p = 0.002 | 200 |
| Loose | 1.6 | 2.2 | n.s. | 197 |
| Root remainders | 0.3 | 0.4 | n.s. | 202 |
| Devital | 0.5 | 1.0 | p = 0.023 | 200 |
| Roots – filled completely | 0.2 | 0.1 | n.s. | 198 |
| Roots – filled incompletely | 0.3 | 0.1 | p = 0.006 | 199 |
| Apical periodontitis | 0.3 | 0.2 | n.s. | 200 |
| Dentogenic cysts | 0.2 | 0.1 | n.s. | 199 |
| Retained teeth | 0.2 | 0.1 | n.s. | 198 |
| Superficial marginal periodontitis (patients) | ||||
| - Localized | 7 (8%) | 33 (29%) | p = 0.002 | 199 |
| - General | 10 (11%) | 16 (14%) | ||
| Profound marginal periodontitis (patients) | ||||
| - Localized | 12 (14%) | 25 (22%)) | p = 0.002 | 201 |
| - General | 35 (40%) | 14 (12%) |
Superficial marginal periodontitis: chronic periodontitis with less to moderate attatchment loss.
Profound marginal periodontitis: chronic periodontitis with severe attatchment loss.
Dental rehabilitation procedures
| Teeth (mean values, n=) | Group A | Group B | Comparison | Data available from n patients |
|---|---|---|---|---|
| Endodontic treatment | 0.05 | 0.03 | n.s. | 200 |
| Removal of root remainders | 0.2 | 0.4 | n.s. | 200 |
| Tooth extraction | 3.7 | 5.8 | p = 0.008 | 202 |
| Conserving treatment | 0.6 | 0.1 | p = 0.008 | 200 |
| Cystectomy | 0.09 | 0.05 | n.s. | 199 |
| Surgical removal | 0.3 | 0.2 | n.s. | 201 |
| Healthy teeth remaining after dental rehabilitation | 6.2 | 4.8 | n.s. | 201 |
Figure 1Development of IORN over time (Kaplan-Meier estimate).
Prognostic factors for the occurrence of IORN (n = 204)
| Univariate analysis | ||
|---|---|---|
| Teeth | p= | Remarks |
| Dental status before starting radiotherapy | ||
| Absent | 0.110 | |
| Present | 0.107 | |
| Carious | 0.026 | Significant |
| Deeply carious destroyed | 0.202 | |
| Loose | 0.104 | |
| Root remainders | 0.595 | |
| Devital | 0.287 | |
| Roots – filled completely | 0.949 | |
| Roots – filled incompletely | 0.789 | |
| Apical periodontitis | 0.888 | |
| Cysts | 0.392 | |
| Retained | 0.1620 | |
| Conservative treatment possible | 0.430 | |
| No conservative treatment possible | 0.179 | |
| Filled | 0.751 | |
| Not sufficiently filled teeth | 0.549 | |
| Teeth with not sufficient crowns | 0.968 | |
| Item | ||
| Chronic periodontitis with less to moderate attatchment loss | 0.418 | |
| Localized | ||
| General | ||
| Chronic periodontitis with severe attatchment loss | 0.210 | |
| Localized | ||
| General | ||
| Dental treatment before radiotherapy | ||
| Endodontic treatment | 0.379 | |
| Removal of root remainders | 0.636 | |
| Tooth extraction | 0.291 | |
| Conserving treatment | 0.603 | |
| Cystectomy | 0.936 | |
| Healthy teeth remaining after dental rehabilitation | 0.158 | |
| Demographic and oncological data | ||
| Age | 0.106 | |
| Karnofsky performance status | 0.625 | |
| T-stage | 0.222 | |
| N-stage | 0.040 | Significant |
| Total dose | 0.005 | Significant |
| BED2 | 0.040 | Significant |
| Daily fraction | 0.036 | Significant |
|
| ||
| Carious teeth | 0.0089 | Significant |
| N-stage | 0.1256 | |
| Total dose | 0.3524 | |
| BED 2 | 0.4182 | |
| Daily fraction | 0.5596 | |
All remaining factors as mentioned in Tables 1 and 2 have been tested univariately and found insignificant, thus they were not tested multivariately.
Dental status and rehabilitation procedures in the literature for IORN in the lower jaw
| Author group | Dental status | Rehabilitation procedures | Remarks |
|---|---|---|---|
| Frydrych and Slack-Smith | No information | No information | Average (median) date of last dental visit: 66.76 months (18 months) before radiotherapy |
| Guggenheimer and Hoffman | Edentulous: 59% | No information | |
| Partially edentulous: 9% | |||
| Poor dentition with no replacement: 14% | |||
| Intact dentition: 18% | |||
| Maier et al. | Tumour vs. control patients: Tartar > 3 mm: 40.91 vs. 21.98% | No information | Tumour vs. control patients |
| Never tooth brushing 44.9 vs. 23.5% | |||
| Decayed teeth >50% : 27.2 vs. 3.9% | Dental visit more than once a year: 6% vs. 43.5% | ||
| Lockhart and Clark | Alveolar bone loss: 66% | Needing dental care: 97% | Noncompliant with routine dental care: 76% |
| Clinical caries: 71% | Did not seek the indicated treatment: 81% | Noncompliant with routine oral hygiene: 65% | |
| Failing restorations: 91% | |||
| Jham et al. | Periodontal disease: 41% | No information | |
| Residual root: 21.2% | |||
| Caries 12% | |||
| Unerupted tooth: 5.8% |
Incidence of IORN of the upper and lower jaw in the literature
| Author group | Incidence | Remarks |
|---|---|---|
| Ben-David et al. | 0 | Multiple tumour localizations |
| Primary treatment (no surgery) | ||
| IMRT | ||
| 108/176 radiochemotherapy | ||
| Berger and Bensadoun | 1-5% | Literature survey |
| Crombie et al. | 36% | 53/54 radiochemotherapy |
| Gomez et al. | 1.2% | Multiple tumour localizations |
| IMRT | ||
| Gomez et al. | 5% | IMRT |
| Jereczek-Fossa and Orecchia | 0.4-56% | Literature survey |
| Jham et al. | 5.5% | Head and neck cancer |
| Katsura et al. | 15% | |
| Lee et al. | 6.6% | Oral cavity and oropharynx |
| Monnier et al. | 40% | Oral cavity and oropharynx |
| Oh et al. | 4.9% | |
| Reuther et al. | 8.2% | Oral cavity and oropharynx |
| Stenson et al. | 18.4% | Surgery, adjuvant radiochemotherapy |
| Storey et al. | 6% | Malignant submandibular tumours |
| Studer et al. | Grade 2 EORTC: 1.6% | Oral cavity and oropharynx |
| Conventional dental care vs. risk-adapted dental care | ||
| IMRT | ||
| Thiel | 4-35% | Literature survey |
| Thorn et al. | 74%/3 years | Multiple tumour localizations |
| Tsai et al. | 7.5% | Oropharyngeal cancer, median time to IORN 8 months |
| Turner et al. | 5.9% |
Risk factors for IORN of the upper and lower jaw in the literature
| Author group | Risk factor(s) | Remarks |
|---|---|---|
| Ahmed et al. | Intensity modulated radiotherapy (IMRT) advantageous compared to conventional radiotherapy | |
| Berger and Bensadoun | Total dose >66 Gy | Literature survey |
| Bhide et al. | Total dose > 60 Gy | Literature survey |
| Volume of mandible within the treatment field. Trauma related ORN after lower doses | ||
| IMRT | ||
| Chopra et al. | White ethnicity | |
| Secondary infection | ||
| Advanced age | ||
| Stage IV | ||
| Total dose | ||
| Post-RT dental extractions | ||
| Lack of pre-RT dental extractions | ||
| Curi and Dib | Oral cancer | |
| Invasion of bone | ||
| Tumour surgery | ||
| Total radiation dose | ||
| Dose rate/day | ||
| Mode of radiation delivery | ||
| Dental status | ||
| Time from radiation therapy until the onset of ORN | ||
| Goldwasser et al. | Higher body mass index | Multivariate analysis |
| Use of steroids | ||
| Radiation dose >66 Gy | ||
| Jereczek-Fossa and Orecchia | Total dose | Literature survey, only part of the factions mentioned in the paper cited here |
| Brachytherapy dose | ||
| Dose per fraction | ||
| Interval between fractions | ||
| Volume of the horizontal ramus of the mandible irradiated with a high dose | ||
| Dental status | ||
| Bad oral hygiene | ||
| Dental extractions after radiotherapy | ||
| Katsura et al. | Oral health status after radiotherapy | |
| Periodontal pocket depth | ||
| Dental plaque | ||
| Alveolar bone loss level | ||
| Radiographic periodontal status | ||
| Lee et al. | Univariate: Mandibular surgery | Multivariate analysis: |
| Co-60 | Mandibular surgery | |
| BED >106.2 Gy | ||
| Lozza et al. | Dose rate | Brachytherapy exclusively |
| Reference volume | ||
| Monnier et al. | Oral cavity tumours | Multivariate analysis: bone surgery |
| Bone invasion | ||
| Surgery prior to radiotherapy | ||
| Bone surgery | ||
| Nabil | Hyperfractionation | Literature survey |
| Reduced risk after accelerated radiotherapy with reduced dose | ||
| Reuther et al. | Advanced tumours | |
| Segmental resection of the mandible | ||
| Tooth extractions (pre/post RT) | ||
| Pre-surgical radiotherapy worse than post-surgical radiotherapy | ||
| Store and Boysen | Tumour localization in tongue and floor of mouth | |
| Trauma | ||
| Thiel | Caries | |
| Periondontosis | ||
| Periapical pathology | ||
| Injury | ||
| Irritation by prostheses | ||
| Dental extractions before and after radiotherapy | ||
| Bone surgery because of remaining or recurrent tumours | ||
| Thorn et al. | Removal of teeth | |
| Surgery | ||
| Injury from prosthesis | ||
| Spontaneous breakdowns | ||
| Tsai et al. | Total dose | |
| Dental status | ||
| Smokers | ||
| Alcohol | ||
| Larger tumours | ||
| Turner et al. | Bone involvement | |
| Synchronous Methotrexate | ||
| Scattered dose from elective neck treatment | ||
| Increasing dose | ||
| Increasing target volumes for doses <55 Gy | ||
| Dental extractions |